everyone achieves greatness at biontech! as one of the most rapidly growing biotechnology companies in europe, we’re working on revolutionary approaches in the fight against cancer and other diseases. over 400 dedicated, passionate pioneers achieve sensational success and promising breakthroughs time and again by forging new paths – and ensure people all around the world have hope for the future. you too can become a pioneer! http://biontech.de/ http://biontech.de/imprint/
Company profile
Ticker
BNTX
Exchange
Website
CEO
Ugur Sahin
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
BNTX stock data
Latest filings (excl ownership)
6-K
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
21 May 24
6-K
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
17 May 24
6-K
Current report (foreign)
6 May 24
6-K
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
6 May 24
6-K
Invitation to the Annual General Meeting 2024
8 Apr 24
6-K
Current report (foreign)
8 Apr 24
6-K
Current report (foreign)
22 Mar 24
20-F
2023 FY
Annual report (foreign)
20 Mar 24
6-K
BioNTech Announces Fourth Quarter and Full Year 2023
20 Mar 24
6-K
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
20 Mar 24
Transcripts
BNTX
Earnings call transcript
2024 Q1
6 May 24
BNTX
Earnings call transcript
2023 Q4
20 Mar 24
BNTX
Earnings call transcript
2023 Q3
6 Nov 23
BNTX
Earnings call transcript
2023 Q2
7 Aug 23
BNTX
Earnings call transcript
2023 Q1
8 May 23
BNTX
Earnings call transcript
2022 Q4
27 Mar 23
BNTX
Earnings call transcript
2022 Q1
9 May 22
BNTX
Earnings call transcript
2021 Q4
30 Mar 22
BNTX
Earnings call transcript
2021 Q3
9 Nov 21
BNTX
Earnings call transcript
2021 Q2
9 Aug 21
Latest ownership filings
144
Notice of proposed sale of securities
28 Feb 24
SC 13D
Autolus Therapeutics plc
21 Feb 24
SC 13G/A
Medine GmbH
14 Feb 24
SC 13G/A
ATHOS KG
7 Feb 24
144
Notice of proposed sale of securities
4 Jan 24
144/A
Notice of proposed sale of securities (amended)
10 Oct 23
144
Notice of proposed sale of securities
29 Sep 23
144
Notice of proposed sale of securities
29 Sep 23
144/A
Notice of proposed sale of securities (amended)
14 Aug 23
144
Notice of proposed sale of securities
29 Jun 23
Financial summary
Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q1 2024
66.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 123 |
Opened positions | 32 |
Closed positions | 131 |
Increased positions | 28 |
Reduced positions | 27 |
13F shares | Current |
---|---|
Total value | 1.21 tn |
Total shares | 159.07 mm |
Total puts | 463.90 k |
Total calls | 275.30 k |
Total put/call ratio | 1.7 |
Largest owners | Shares | Value |
---|---|---|
Athos KG | 104.05 mm | $0.00 |
Medine GmbH | 40.44 mm | $0.00 |
Baillie Gifford & Co | 8.36 mm | $771.11 bn |
Flossbach Von Storch | 3.47 mm | $320.01 bn |
MIG Verwaltungs | 700.85 k | $57.13 mm |
DekaBank Deutsche Girozentrale | 411.90 k | $38.29 mm |
La Financiere De L'echiquier | 214.11 k | $19.75 bn |
Candriam Luxembourg S.C.A. | 160.30 k | $14.79 bn |
Robeco Institutional Asset Management B.V. | 140.91 k | $13.00 bn |
Baader Bank | 135.10 k | $12.46 bn |
News
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb
22 May 24
'Disease Experts Predict A Small Rise In Covid-19 Cases This Summer' - CNBC
22 May 24
Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday
22 May 24
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
17 May 24
'Moderna Wins Case In Patent Dispute With Pfizer And BioNTech Over Covid Jab; Decision Is A Boon For The mRNA-Vaccine Maker In Its Legal Fight To Recoup Pandemic Profits From Rivals' - Financial Times
17 May 24
Press releases
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
21 May 24
Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term
21 May 24
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
17 May 24
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
6 May 24
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
7 Apr 24